Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Condensed Consolidated Statements of Operations (Unaudited) | ||||
| Revenues | $ 87,200 | $ 2,121 | $ 594,563 | $ 16,563 |
| Cost Of Revenues | (41,078) | (1,249) | (184,181) | (11,277) |
| Gross Margin | 46,122 | 872 | 410,382 | 5,286 |
| Operating Expenses: | ||||
| Research And Development Expenses | 1,577,454 | 0 | 1,920,645 | 389 |
| Selling, General And Administrative Expenses | 551,730 | 522,981 | 2,357,163 | 1,445,332 |
| Total Operating Expenses | 2,129,184 | 522,981 | 4,277,808 | 1,445,721 |
| Operating loss | (2,083,062) | (522,109) | (3,867,426) | (1,440,435) |
| Non-operating income and expenses, net | ||||
| Interest expenses, net | (16,687) | (11,897) | (18,689) | (10,185) |
| Other losses | (146) | 0 | (2,547) | (3) |
| Total non-operating income and expenses, net | (16,833) | (11,897) | (21,236) | (10,188) |
| Net loss | $ (2,099,895) | $ (534,006) | $ (3,888,661) | $ (1,450,623) |
| Basic and diluted net loss per average share available to common shareholders | $ (0.01) | $ (0.01) | $ (0.03) | $ (0.04) |
| Weighted average common shares outstanding- basic and diluted | 144,379,308 | 42,066,172 | 113,270,245 | 40,730,934 |